COMP <GO>
ACNT vs FCX // RETURN ON INVESTED CAPITAL (ROIC)
Ascent Industries Co. (NASDAQ) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: ACNT 2
— FCX 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: FCX
LAST: $13.75 (-0.36%) • MKT CAP: $124.3M
roic
-18.90%
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
roic
21.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACNT VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACNT | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.00% | 26.10% | -3.10 | FCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -18.90% | 21.50% | -40.40 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.66% | 4.71% | -6.37 | FCX | /fcf-yield <GO> |
| Operating Margin | -9.40% | 25.90% | -35.30 | FCX | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 8.80% | -7.60 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) | -7.20% | 0.10% | -7.30 | FCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.91% | -0.91 | FCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.78 | 3.08 | +1.70 | ACNT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.7 | 43.5 | +3.20 | ACNT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 133.4x | 40.1x | +93.30 | FCX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $124.3M | $94.98B | -$94.85B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACNT REV | FCX REV | ACNT GROSS % | FCX GROSS % | ACNT FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $74.9M | $25.19B | 23.0% | 26.1% | -$2.1M | $4.48B |
| FY 2024 | $80.8M | $25.17B | 13.2% | 29.3% | $13.6M | $6.03B |
| FY 2023 | $193.2M | $22.70B | — | — | $23.1M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACNT // BETA —
FCX // BETA 0.95